Category: Pharma

Greetings, dear readers! Today, we embark on a whimsical journey through the enchanting realm of the biopharma industry. Imagine a world where science dances with imagination, where molecules hold the key to curing ailments, and where innovation reigns supreme. Join me as we unravel the mysteries and marvels of this captivating domain. As we delve […]

In the vast landscape of pharmaceuticals, a seemingly unassuming compound, P-Toluenesulfonic Acid (PTSA), emerges as a silent powerhouse, driving growth and innovation within the industry. As the pharmaceutical sector continues its trajectory of steady expansion, the demand for high-quality PTSA is set to soar, propelling the Pharmaceutical Grade PTSA market to reach a staggering USD […]

In the realm of biotechnology, a groundbreaking innovation has emerged with the development of Bimiralisib gel, demonstrating remarkable efficacy in the treatment of early-stage actinic keratosis. This transformative therapy has recently undergone a Phase 2 clinical trial, unveiling compelling results that pave the way for a paradigm shift in dermatological care. Unveiling the Potential: Bimiralisib […]

Greetings, dear readers! Today, we embark on a journey through the fascinating realm of biopharma industry collaborations. Join me as we delve into the exciting partnership between Impilo and Current Health, two innovative powerhouses merging their expertise to revolutionize supply chain visibility. Picture this: a seamless flow of information traversing the intricate network of the […]

In a surprising turn of events, renowned biopharma executive, Sarah Concannon, has been appointed as the interim CEO of Qore, a groundbreaking venture by the global giant Cargill. This unexpected move has sent ripples of excitement and curiosity throughout the industry, as Concannon brings with her a wealth of experience and a reputation for innovation […]

Greetings, fellow enthusiasts of biopharmaceutical wonders! Today, we embark on a captivating exploration into the realm of non-invasive pH monitoring, where the marriage of Good buffers and Raman spectroscopy unveils a tapestry of innovation and precision. Imagine a world where pH measurement transcends traditional boundaries, offering real-time insights without perturbing the delicate equilibrium of biological […]

Greetings esteemed readers, today we delve into the exciting realm of biopharmaceuticals, where groundbreaking research and innovative technologies converge to shape the future of healthcare. Our focus centers on the esteemed Hansa Biopharma and its pivotal role in two upcoming healthcare investor conferences: Optimum’s 17th Annual Healthcare Investor Conference and Nordic Life Science Days 2025. […]

Embark on a journey with Natalie Bedford, a seasoned expert in navigating the intricate landscape of pharmaceutical distributor partnerships. In a world where collaborations can make or break a company, Natalie’s insights are invaluable. Let’s unveil the secrets to thriving in the pharmaceutical distribution realm. The Importance of Strategic Partnerships In the pharmaceutical industry, distributor […]

In the landscape of regulatory pharmaceutical affairs, the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) stands as a pivotal player. The MHRA International Recognition Procedure serves as a conduit for ensuring the quality, safety, and efficacy of medicinal products entering the UK market. This intricate process involves a series of rigorous evaluations and […]

In the realm of pharmaceutical marketing, the landscape has been tumultuous in recent years, particularly under the regulatory changes brought about during the Trump administration in the United States. These shifts have prompted pharma marketers to adapt rapidly to a changing environment, rethinking strategies and compliance measures to navigate this regulatory whiplash effectively. The Impact […]

In the realm of clinical development strategy, biosimilar insulin has emerged as a captivating enigma, entwined with the threads of lower prices while navigating the labyrinthine landscapes of regulatory expectations. This innovative class of therapeutics holds the promise of cost-effectiveness and expanded access for patients across Europe, drawing the attention of strategic minds seeking to […]

In a landmark decision, a recent court ruling has granted Medicare the authority to negotiate prices for a broader range of drugs, marking a significant shift in the landscape of pharmaceutical pricing. This ruling is poised to have far-reaching implications not only for the healthcare industry but also for patients, policymakers, and drug manufacturers alike. […]

Introduction: In the realm of radiopharmaceutical development, the intersection of preclinical precision and evolving FDA oversight marks a pivotal moment. With advancements in technology and increased regulatory scrutiny, the landscape of radiopharmaceutical research is undergoing a transformative shift. This paradigm shift requires a comprehensive understanding of multi-omics integration, data pipelines, and topological principles to ensure […]

In the realm of healthcare, a battleground rages on, with fiery debates and power struggles marking the dispute over extending health care subsidies. At the heart of this conflict lies a complex web of interests, ideologies, and policies, each vying for dominance in shaping the future of healthcare provision. To fully comprehend this dispute, one […]

Advanz Pharma and Alvotech have achieved a significant milestone as the European Medicines Agency (EMA) accepted the Marketing Authorization Application for AVT23, a proposed biosimilar to Xolair (omalizumab). This move signifies a crucial step towards enhancing access to high-quality yet affordable biologic medicines for patients across Europe. The collaboration between Advanz Pharma and Alvotech underscores […]

In the realm of drug development, the landscape of resourcing and outsourcing is undergoing a significant transformation. Insights gleaned from interviews with key figures in the biopharmaceutical industry shed light on the emerging trends that are reshaping traditional models of clinical trial resourcing. These trends point to a shift away from conventional full-service Contract Research […]

In the ever-evolving landscape of drug development, pharmaceutical manufacturing processes face significant challenges in keeping up with the pace of innovation. The adoption of Artificial Intelligence (AI) in this sector is not just an opportunity for improvement but is increasingly becoming a competitive necessity. The implementation of AI in pharmaceutical manufacturing addresses critical issues such […]

In the grand orchestra of biotherapeutics, where the melodies of monoclonal antibodies once dominated, a crescendo of complexity now emerges. Multi-target proteins, engineered proteins, and bioconjugates take center stage, challenging the traditional boundaries of pharmaceutical development. As these novel and intricate molecules weave their symphony of potential, the need for innovative strategies in automated resin […]

Diversification for Growth In a strategic move to bolster its cargo operations, Hyderabad Airport is expanding its existing terminal and constructing a new one dedicated to handling an impressive 50,000 tonnes of cargo. While the airport has been renowned for its rapid growth in international cargo volume fueled by pharmaceutical exports, it is now shifting […]

Sun Pharma, India’s largest drugmaker, has recently undergone significant leadership changes, a move that marks a strategic long-term transition for the company. The shuffle encompasses critical functions such as the India business, the US operations, and the focus on long-term specialty pharmaceuticals. Kirti Ganorkar, who previously led the India business, has taken on the role […]

In the realm of ophthalmology, a transformative wave of biobetter drugs and biosimilars is cresting on the horizon, poised to revolutionize treatment paradigms and potentially capture market share from conventional reference products. A recent review has shed light on the burgeoning landscape of biobetter and biosimilar development in ophthalmic conditions, heralding a new era of […]

India’s Pharmacovigilance Revolution: A Call to Action In the realm of pharmacovigilance, India stands tall, a beacon of proactive reporting and public health protection. Spearheaded by the Indian Pharmacopoeia Commission, the 5th National Pharmacovigilance Week heralds a new era of heightened vigilance, rallying healthcare professionals and patients alike to actively engage in reporting adverse drug […]

In the intricate dance of power and wealth within the pharmaceutical realm, every move is scrutinized, every transaction analyzed for its implications. Recently, the CEO of Rigel Pharmaceuticals, Raul Rodriguez, made a bold move that reverberated through the industry. Acquiring stock options worth a staggering $388K, Rodriguez’s actions were not merely financial but symbolic, a […]

Amidst the dynamic fluctuations of the stock market, the pharmaceutical sector recently experienced a notable resurgence following the Federal Reserve’s decision to implement a 25 basis point rate cut. This move catalyzed a positive shift in the Nifty Pharma index, propelling it to a gain of 0.62%, a commendable ascent from its previous position. Notably, […]

KRAS, a prominent oncogene with high mutation rates in various cancers, was long deemed impervious to drug targeting. However, recent scientific breakthroughs have paved the way for the development of therapies specifically designed to combat KRAS mutations, particularly the challenging G12C, G12D, and G13D variants. At Medicilon, we pride ourselves on offering a comprehensive suite […]

In the fast-paced world of biopharmaceuticals, the mantra “Connection Is Competitiveness” rings truer than ever before. Recently, at the 2025 World Bio Summit hosted by the Ministry of Health and Welfare, industry experts delved into the critical importance of linking regional bio clusters through global networks to not just survive but thrive in the fiercely […]

A recent study featured in the Journal of American Medical Association sheds light on the heightened risk of intraocular hemorrhage requiring vitrectomy in patients with exudative age-related macular degeneration (AMD) who are using anticoagulants or antiplatelets. The research, based on data from the Korean Health Insurance Review and Assessment Service, scrutinized records of over 1,49,000 […]

In a groundbreaking development, the FDA has recently given its seal of approval to Bosaya and Aukelso, two denosumab biosimilars brought to the market by Biocon Biologics. These approvals mark a significant milestone in the realm of biopharmaceuticals, offering more accessible treatment options for individuals battling osteoporosis and bone-related cancers. Let’s delve deeper into the […]

Blue Shield of California has stepped onto the stage of healthcare economics with a bold announcement: the introduction of Idacio, an adalimumab biosimilar, at a price point that slashes the cost by a staggering 75% compared to the reference product Humira. This move is set to revolutionize the landscape for patients battling inflammatory diseases who […]

In the realm of pharmaceuticals, where the dance of innovation meets the rhythm of regulation, the unveiling of Mounjaro’s sales impact on Eli Lilly’s UK turnover serves as a captivating overture. This symphony of financial crescendo, with a 90% surge in turnover, showcases the harmonious interplay between market dynamics and strategic maneuvers within the pharmaceutical […]

Sun Pharmaceutical Industries Ltd, India’s leading drugmaker, has garnered attention with Citi’s endorsement, being named a top pick on its Pan Asia Focus List. Citi’s ‘Buy’ rating and a price target of Rs 2,180 per share, indicating a potential 35% upside, are underpinned by Sun Pharma’s anticipated innovation surge and blockbuster US approvals. The brokerage […]

Nigeria’s pharmaceutical industry has emerged as a beacon of growth within the stock market, with notable companies like Fidson and May & Baker experiencing substantial gains in 2025. Despite the country grappling with inflation and currency fluctuations, investors are increasingly turning to healthcare firms for both growth and stability. This shift in focus towards healthcare […]

In a recent report by ICRA, Indian pharma companies are projected to see a robust revenue growth of 7-9% in the fiscal year 2026. Despite this positive outlook, the U.S. market poses certain risks due to factors such as price erosion, regulatory scrutiny by the U.S. FDA, and the impact of recent tariffs on Indian […]

In the intricate dance of the pharmaceutical world, where uncertainties loom and regulatory winds blow strong, the Indian pharma industry stands resilient, projected to grow between 7-9% in FY26, as forecasted by the discerning eye of ICRA. Despite the looming shadows of regulatory scrutiny and tariffs, the industry anticipates a moderate yet steady growth trajectory, […]

Dean Schorno, the Executive Vice President and Chief Financial Officer at Rigel Pharmaceuticals, recently made a strategic play by acquiring stock options for 7,394 shares of the company. This move, disclosed in a Form 4 filing with the SEC, showcases Schorno’s confidence in Rigel’s potential growth and success. Rigel Pharmaceuticals is a renowned biotech company […]

India’s pharmaceutical sector, valued at a staggering $1.48 trillion in 2022, serves as a cornerstone of the nation’s economy, offering a myriad of opportunities for growth and prosperity. However, for aspiring entrepreneurs venturing into this competitive arena, challenges surrounding reliability and industry expertise loom large. Enter PharmaAdda, a groundbreaking initiative designed to serve as a […]

India’s pharmaceutical industry is poised for robust revenue growth of 7-9% in FY26, driven by domestic and European markets, despite facing challenges in the US market. Factors such as enhanced rural distribution, new product launches domestically, and increased R&D investments are key drivers of this growth trajectory. ICRA’s recent sector outlook forecasts a significant revenue […]

Critical medicines shortages persist in the European Union, indicating a dire need for regulatory reform, as highlighted in a recent report by the European Court of Auditors unveiled on Wednesday, September 17th. From January 2022 to October 2024, the EU documented shortages of 136 crucial medicines, shedding light on the severity of the issue. Although […]

Intas Pharmaceuticals has recently received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct an Active Post Marketing Surveillance (PMS) Study of Tacrolimus Lipid Suspension for Enema 4 mg/vial. This approval comes with the recommendation to include kidney function tests (KFT) and blood pressure monitoring for the study volunteers. The study aims to […]

AstraZeneca recently disclosed the topline data from the RESOLUTE Phase 3 trial of Fasenra (benralizumab), shedding light on its efficacy in patients with chronic obstructive pulmonary disease (COPD), commonly referred to as smoker’s lung disease. Despite demonstrating numerical improvements, Fasenra fell short of achieving statistical significance in the primary endpoint. This development poses intriguing challenges […]

Pharmacovigilance, the monitoring and assessment of drug safety, is a crucial aspect of healthcare that often involves healthcare professionals but rarely includes active participation from patients. Dr. Rajeev Singh Raghuvanshi, the Drugs Controller General of India (DCGI), emphasized the importance of patients playing a proactive role in pharmacovigilance during the 5th National Pharmacovigilance Week held […]

In the realm where pharmacology, biochemistry, and neuroscience converge, lies the intriguing work of Thomas Keck, a distinguished professor at Rowan University. With a fervent interest in formulating novel medications, Keck’s research journey is supported by the National Institute on Drug Abuse of the National Institutes of Health. His laboratories, spread across Rowan University in […]

Pharmacoepidemiology, a discipline born from the necessity to assess the real-world effects of drugs, delves deep into the realms of drug efficacy, adverse reactions, and patterns of usage. While randomized clinical trials stand as the gold standard for demonstrating drug efficacy, their controlled settings often fail to mirror real-world scenarios. Pharmacoepidemiologic studies bridge this gap, […]

In a recent twist of events, the infamous Martin Shkreli, affectionately dubbed ‘Pharma Bro,’ revealed his short position against the iBuying real estate giant, Opendoor Technologies Inc. under the ticker symbol OPEN. This announcement came as a bombshell, shaking the financial world and igniting curiosity among investors and market enthusiasts alike. Shkreli, known for his […]

Labour’s commitment to bolster NHS medicine spending reflects a critical juncture as the UK faces a potential exodus of global pharmaceutical firms. Lord Vallance, the former chief scientific adviser, highlighted the repercussions of diminishing allocations towards medicines within the NHS, emphasizing the need for a reversal in this trend. The decline in the proportion of […]

Lupin, a stalwart in the pharmaceutical industry, has recently faced a setback as its shares experienced a decline of nearly 2% following the revelation that the US Food and Drug Administration (USFDA) issued six observations after inspecting its Nagpur injectable facility. This development has not only impacted Lupin’s market performance but has also brought to […]

Pharma giant GSK has made headlines with its substantial commitment of at least $30 billion in the United States over the next five years. This move comes as President Trump visits the UK, highlighting the strong ties between the two nations in science and healthcare innovation. GSK CEO Emma Walmsley emphasized the company’s pride in […]

The UK drug discovery landscape is currently facing tumultuous times, as highlighted by the recent remarks of AstraZeneca’s UK president, Tom Keith-Roach. In his testimony before MPs, Keith-Roach painted a stark picture of the challenges encountered in developing and delivering new drugs to patients within the UK. The pharmaceutical giant’s decision to halt a planned […]

Pharmaceutical vials, the unsung heroes of drug storage and delivery, are set to undergo a significant transformation in the coming years. With the global pharmaceutical industry expanding at a rapid pace, the demand for safe and reliable packaging solutions is higher than ever. Valued at USD 13.9 billion in 2025, the pharmaceutical vials market is […]

In recent news, Mark Schneyer, the Executive Vice President at ACADIA Pharmaceuticals, made headlines by disclosing an insider sell of 3,498 shares of the company, amounting to a total value of $82,727. This transaction, filed with the U.S. Securities and Exchange Commission, has sparked interest and raised questions about the implications of insider trading in […]

Ah, the mesmerizing world of macroalgae! These marine wonders, with their captivating hues and intricate structures, hold within them a treasure trove of bioactive substances that are revolutionizing the fields of food and pharmaceuticals. Join me on a journey to explore the boundless potential of macroalgae-derived multifunctional bioactive substances and their diverse applications in our […]

India’s pharmacy education landscape is undergoing a transformative shift, marked by a groundbreaking update to the curriculum that underscores the importance of innovation, practical training in industrial settings, and alignment with contemporary pharmaceutical industry standards. The Pharmacy Council of India (PCI) has introduced a new draft syllabus that emphasizes regulatory compliance, quality systems, and Good […]

Serena Williams, the iconic tennis legend, has made waves by endorsing GLP-1s in a recent advertisement for Ro, a telehealth provider. While her bold stance is commendable, it raises questions about the transparency of drug promotion and the regulatory oversight faced by pharmaceutical companies. The Power of Celebrity Endorsement In the world of marketing, celebrity […]

In a recent showdown between the FDA and pharmaceutical giants Eli Lilly and Novo Nordisk, the regulatory agency accused the companies of understating the risks associated with their GLP-1 weight loss drugs during a prime time special with Oprah Winfrey. The FDA’s latest crackdown on deceptive and misleading advertisements targeted Eli Lilly for its promotion […]

Welcome to the latest edition of Pharmaceutical Executive Daily, where we delve into the cutting-edge developments shaping the biopharmaceutical landscape. Today, we bring you exciting updates on key advancements in the pharmaceutical industry, highlighting groundbreaking therapies and pivotal regulatory approvals that are set to revolutionize patient care and treatment outcomes. First on the agenda is […]

In a bold move echoing across Maharashtra’s government medical colleges, resident doctors and interns are making their voices heard through a silent protest adorned with black ribbons. The bone of contention? The controversial decision to register homoeopathy practitioners who have obtained a Certificate Course in Modern Pharmacology (CCPMP) with the Maharashtra Medical Council (MMC). Unveiling […]

A recent legal battle has rocked the pharmaceutical industry, centered on the Medicare Drug Price Negotiation Program. This program, established under the Inflation Reduction Act, aims to allow Medicare to negotiate drug prices directly with pharmaceutical companies, potentially reducing costs for older Americans. However, several major pharmaceutical companies, including Johnson & Johnson, Bristol Myers Squibb, […]

Molecular glues, small compounds adept at stabilizing protein-protein interactions in a specific manner, are pivotal in modulating various cellular processes. These compounds excel at enhancing associations with the proteasome, leading to targeted protein degradation, and facilitating interactions with native or engineered proteins. Their emergence in pharmaceutical research is marked by the promising ability to target […]

AstraZeneca, a key player in the biopharma industry, recently made headlines by suspending its £200 million investment in the U.K., equivalent to approximately $271 million. This decision comes as a significant pivot, especially considering the company’s earlier plans to bolster its presence in the country with a substantial financial commitment. The move reflects broader trends […]

Lingonberry leaves are a hidden gem, brimming with potent bioactive compounds that outshine the berries themselves. With a rich array of phenolics, these leaves have long been overlooked despite their remarkable health benefits. Recent studies have unveiled the superior antioxidant capacity of lingonberry leaves compared to the fruit, paving the way for their integration into […]

Welcome to the vibrant world of Pharma Pulse, your go-to source for the latest buzz in pharmaceuticals and healthcare innovations. I’m your enthusiastic host, here to delve into the FDA’s groundbreaking efforts to fast-track non-opioid pain treatments, the FTC’s crackdown on restrictive employment contracts in healthcare, and DHL Supply Chain’s strategic move to revolutionize last-mile […]

Sun Pharma, a prominent player in the pharmaceutical industry, recently emerged victorious in a trademark dispute concerning its liver drug trademark URSOCOL. The Bombay High Court granted Sun Pharma Laboratories Limited an interim injunction against Rambos Lifesciences Pvt. Ltd., prohibiting the use of the trademarks URSOCAL and URSOCAL-300. The court deemed these marks to be […]

The Indian pharmaceutical industry has established itself as a key player on the global stage, leveraging its robust manufacturing capabilities and focus on research and development. To further drive growth and innovation, Indian pharma companies are increasingly turning to strategic partnerships and licensing agreements. These collaborations not only enhance their product portfolios but also enable […]

The landscape of innovation in India’s pharmaceutical and medical technology sectors is on the brink of transformation, as the government gears up to introduce a groundbreaking initiative aimed at fostering research and development. The Promotion of Research and Innovation in Pharma MedTech sector (PRIP) scheme, set to be officially launched within this month, carries the […]

India is on the cusp of launching a groundbreaking initiative, the Promotion of Research and Innovation in Pharma MedTech (PRIP) scheme. This visionary program, with a substantial budget of Rs 5,000 crore, is strategically designed to elevate the research and development ecosystem in the pharmaceutical and medical technology sectors. By providing financial backing that covers […]

In the fast-paced realm of biopharma and life sciences, maintaining the integrity of temperature-sensitive products during transportation is paramount. Thermal modeling has emerged as a vital tool in optimizing cold chain packaging design to ensure product efficacy and safety. By leveraging heat transfer and fluid dynamics equations, thermal modeling allows for the prediction of temperature […]

President Donald Trump’s focus on reshoring pharmaceutical manufacturing to the United States has sparked debates on the resilience of the country’s supply chain. Amidst concerns of over-reliance on local production facilities, questions arise regarding the balance between domestic and international sourcing to ensure uninterrupted access to critical medicines. Let’s delve into how these reshoring efforts […]

Global pharmaceutical leaders are bolstering their manufacturing presence in the United States to counter the potential impact of looming tariffs imposed by the Trump administration. Companies such as Eli Lilly, Roche, and AstraZeneca are making significant investments to enhance stability, generate employment opportunities, and expand their production capabilities within the country. Rising U.S. Manufacturing in […]

In the fast-paced world of pharmaceuticals, ensuring the safe and efficient delivery of medicines is paramount. The recent collaboration between Phononic and Peltier marks a significant step towards enhancing cold chain management, ultimately reducing waste, preventing errors, and bolstering the reliable distribution of life-saving medications to patients globally. The Power Duo: Phononic and Peltier Phononic, […]

In a bid to revolutionize the pharmaceutical cold chain industry, the Cold Chain Community, a dynamic business platform endorsed by the National Accreditation Body for Cold Chain Management (NAB-CCM), is gearing up to host a one-day conference on November 4, 2025, in the vibrant city of Ahmedabad. With staunch support from the Gujarat Food and […]

Basilea Pharmaceutica Ltd, a renowned biopharmaceutical company based in Allschwil, Switzerland, has recently made a significant stride in advancing its novel antifungals, fosmanogepix and BAL2062, with the reception of USD 25 million funding under the Biomedical Advanced Research and Development Authority (BARDA) agreement. This funding injection stems from Basilea’s commitment to addressing severe bacterial and […]

Cold Chain Technologies has unveiled a pair of groundbreaking digital tools, namely CCT Route Pro and CCT Lane Risk, aimed at revolutionizing how specialty pharmacies handle temperature-sensitive medications by leveraging predictive weather and shipping data. Cold Chain Technologies (CCT), a prominent player in temperature-controlled packaging distribution, is spearheading a transformation in how specialty pharmacies approach […]

In the realm of botanical wonders, the peyote cactus, scientifically known as Lophophora williamsii, stands out for its profound impact on human consciousness. This remarkable cactus harbors a plethora of biologically active alkaloids, with mescaline reigning as the primary psychedelic compound responsible for inducing profound psychoactive effects. The mechanism through which mescaline exerts its influence […]

Introduction: In the intricate realm of drug discovery, where innovation and precision dance hand in hand, the concept of molecular glues emerges as a captivating protagonist, offering a unique avenue for therapeutic advancement. These molecules, characterized by their ability to mediate protein-protein interactions and modulate cellular processes, have garnered increasing attention as promising tools in […]

Wokha, a quaint district nestled in the northeastern state of Nagaland, has recently been making waves in the agricultural sector as it emerges as a prominent hub for banana cultivation under the One District One Product (ODOP) initiative. This picturesque region, known for its lush green landscapes and vibrant tribal culture, is now gaining recognition […]

In the dynamic realm of the biopharmaceutical industry, where science and business intertwine, a myriad of advancements and challenges constantly shape the landscape. One recent event that has sparked both concern and curiosity is the recall of certain beers due to a ‘precautionary’ labelling alert. This incident serves as a reminder of the intricate processes […]

AstraZeneca recently announced the suspension of its $271 million expansion project at its Discovery Center in Cambridge, Massachusetts. The decision to pause the expansion, which aimed to accommodate the company’s growing research and development activities, comes amidst uncertainties surrounding the future direction of the pharmaceutical industry and the impact of the ongoing global health crisis. […]

Welcome to the dynamic realm of biopharma where the future is shaped by today’s groundbreaking discoveries and innovations. As we anticipate tomorrow’s news in the biopharma industry, it’s essential to delve into the complexities of this ever-evolving field that holds the key to revolutionizing healthcare. From cutting-edge research to transformative therapies, the world of biopharma […]

Phononic and Peltier, two industry leaders in cooling technology and cold chain management, have joined forces to enhance the safety and efficiency of pharmaceutical supply chains worldwide. This groundbreaking partnership aims to tackle the challenges of drug waste, errors, and unreliable delivery of crucial medications to patients, marking a significant step towards a more secure […]

PMV Pharmaceuticals has recently unveiled promising interim data from the Phase 2 pivotal portion of the PYNNACLE clinical trial, showcasing the efficacy of rezatapopt in patients with advanced solid tumors harboring the aTP53Y220C mutation. This development marks a significant milestone in the field of oncology, offering hope for patients with challenging-to-treat cancers. The data, as […]

Mirum Pharmaceuticals, a biopharmaceutical company specializing in therapies for rare and orphan diseases, has garnered the attention of 6 analysts in the past three months. These analysts have provided a range of perspectives on Mirum Pharmaceuticals, offering insights into the company’s performance and potential future trajectory. By delving into their evaluations, price targets, and market […]

The landscape of healthcare spending in Delaware is undergoing a transformation, driven by the increased utilization of GLP-1 medications such as Wegovy and Ozempic. Contrary to common belief, the surge in spending is not primarily due to inflated drug prices but rather stems from a significant rise in the number of individuals using these medications. […]

In the realm of pharmaceutical advertising, the recent remarks by FDA Chief Martin Makary have sparked a significant discourse on the regulatory landscape surrounding direct-to-consumer drug promotions. Makary’s assertion of a “public health crisis” arising from misleading pharmaceutical ads sheds light on the longstanding regulatory failures that have allowed this issue to persist. This shift […]

AstraZeneca, a prominent British pharmaceutical company, has recently made headlines by pausing its planned £200m research facility investment in Cambridge, UK. This move, alongside a previous decision to shelve a £450m investment in a vaccine manufacturing plant in northern England, reflects a shifting landscape in the pharmaceutical industry. Reports from Reuters indicate that the anticipated […]

In the realm of bioprocessing, a domain often dominated by male figures, a cohort of extraordinary women is making significant strides, reshaping the landscape with their ingenuity and leadership prowess. While the gender gap in STEM fields remains a glaring issue, these pioneering women are not just breaking barriers but are setting new standards, driving […]

Indonesia’s pharmaceutical landscape stands under the watchful eye of BPOM, the country’s Food and Drug Monitoring Agency. This regulatory body plays a pivotal role in ensuring the safety and integrity of the nation’s pharmaceutical supply chains. By collaborating with various entities, such as Barantin and health offices like Mataram, BPOM aims to fortify the foundation […]

The bacteriological testing market, valued at USD 25.83 billion in 2025, is forecasted to reach USD 37.26 billion by 2030 at a CAGR of 7.6%. This growth is driven by the increasing demand for reliable testing solutions in industries like food & beverage, water, pharmaceuticals, cosmetics, and healthcare. Technological advancements have led to a shift […]

In the realm of biopharmaceuticals, the development of robust analytical methods is paramount to ensuring product quality and efficacy. Peptide mapping, a technique used to confirm the identity of protein therapeutics and monitor post-translational modifications, plays a pivotal role in this process. The optimization of peptide mapping protocols is a delicate dance between maximizing digestion […]

In the fast-paced world of pharmaceuticals and chemicals, the stability of enzymes and proteins is crucial. These biologics are potent therapeutic agents and essential in industrial processes, but their delicate nature makes them prone to degradation under various stresses like freeze-thaw cycles, vacuum-drying, and freeze-drying. To combat these challenges, extensive research has been conducted on […]

Biosimilars, a revolutionary class of biologic medicines, have been making waves in the Australian healthcare landscape by significantly reducing costs, improving access to essential treatments, and fostering healthy price competition within the pharmaceutical market. A recent study published in Value in Health Regional Issues sheds light on the economic implications of biosimilars in Australia, revealing […]

Artificial Intelligence (AI) stands as a transformative force that promises to catapult India into a realm of unprecedented economic expansion, as articulated by the visionary roadmap unveiled by NITI Aayog and Niti Frontier Tech Hub in New Delhi. The report, “AI for Viksit Bharat: The Opportunity for Accelerated Economic Growth”, not only paints a vivid […]

InflaRx, a pioneering biopharmaceutical company, focuses on combatting life-threatening and chronic inflammatory diseases through innovative science and the development of transformative treatments. By targeting the C5a/C5aR signaling pathway of the immune system’s complement cascade with proprietary anti-C5a and anti-C5aR inhibitors, InflaRx aims to address high unmet medical needs in the field. The company’s pipeline boasts […]

In the fast-paced world of biopharma innovation, the FDA’s regulatory decisions hold immense significance, shaping the future of groundbreaking therapies from industry giants like Merck, Sanofi, Biogen, and more. Delving into the imminent decisions set for the latter half of September unveils a tapestry of strategic moves, clinical data, and patient impact awaiting regulatory verdicts. […]

Merck, the renowned American pharmaceutical company also known as MSD in Europe, recently made waves by scrapping its ambitious £1 billion plan for a new London headquarters. This move has not only dealt a significant blow to the UK government’s aspirations of fostering a world-leading life sciences economy but has also shed light on the […]

The current global health landscape is experiencing significant shifts and updates in the pharmaceutical industry and regulatory environment. Recent events include Intercept Pharma’s withdrawal of a liver drug in the US, China’s enactment of food safety legislation, and upcoming FDA discussions on AI mental health devices. Simultaneously, AstraZeneca’s decision to halt investments in the UK […]

Howard Lutnick, the U.S. Commerce Secretary, recently drew attention to Switzerland’s pharmaceutical industry, highlighting its significant wealth generation through drug exports to the United States. In a candid interview on Bloomberg Television’s Surveillance, Lutnick pointed out Switzerland’s economic prosperity, attributing it to the robust sales of pharmaceuticals to the American market. He emphasized the substantial […]

Cold Chain Technologies (CCT) is revolutionizing the management of cold chain logistics for specialty pharmacies through the introduction of innovative digital applications – CCT Route Pro and CCT Lane Risk. These cutting-edge tools are designed to enhance efficiency, ensure compliance, and deliver substantial cost savings, ultimately transforming how specialty pharmacies operate in the ever-evolving healthcare […]

In the ever-evolving landscape of healthcare, the optimization of pharmacy benefits holds a critical role in ensuring comprehensive and effective care for individuals. Recently, RxBenefits, a pioneering Pharmacy Benefits Optimizer (PBO), introduced Illuminate Rx, a groundbreaking Pharmacy Benefit Manager (PBM) designed by pharmacists to cater to the unique needs of brokers and self-funded employers. At […]

In a world where precision and calculated risks reign supreme, Defiance ETFs have once again defied the norm by introducing their latest leveraged product on Sept. 3 – the Defiance Daily Target 2X Short LLY ETF (LLYZ). This innovative fund is specifically tailored for traders who are keen on shorting the pharmaceutical giant, Eli Lilly […]

In a groundbreaking move, the Goods and Services Tax (GST) Council recently announced significant reforms during its 56th meeting, sparking enthusiasm among pharma industry experts who foresee a positive impact on the accessibility of life-saving drugs and the enhancement of public health. Under the astute leadership of Finance Minister Nirmala Sitharaman, the GST Council streamlined […]

Pharmacists are often seen as the unsung heroes of the healthcare system, playing a crucial role in ensuring the safe and effective use of medications. In a recent study by Al Hamarneh and team, hospital pharmacists in Alberta were asked about their perceptions of their role. The findings revealed a focus on drug-related activities rather […]

Gilead Sciences, a leading pharmaceutical company, has unveiled an ambitious plan to invest $32 billion in constructing state-of-the-art AI-driven pharmaceutical factories in the United States. At the forefront of this initiative is the development of an AI-enabled laboratory in Foster City, California, set to revolutionize oncology and inflammation research while catalyzing growth in the US […]

In the vibrant landscape of India’s pharmaceutical sector, the year 2025 shines brightly with soaring export levels and a continuous influx of foreign investments. The regulatory scene has undergone significant enhancements, marked notably by the revamped CDSCO official website and the complete adoption of the ONDLS platform by state authorities. These updates have not only […]

In recent years, Indian pharmaceutical companies have been undergoing a strategic transformation, moving beyond the realm of producing mere replicas of established drugs. Instead, these companies are increasingly embracing the 505(b)(2) regulatory pathway established by the US FDA to develop distinctive, value-added generics. Dr. Hemagir Gosavi, the manager of the formulation and technology center at […]

Union Minister for Commerce and Industry, Piyush Goyal, delivered a compelling address at the 11th edition of the International Exhibition on Pharmaceuticals and Healthcare (iPHEX 2025), underscoring India’s pivotal position in global healthcare. The event, organized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil), served as a platform to discuss India’s role as the […]

In the complex landscape of pharmaceutical markets, understanding how global drug pricing policies can inform regulatory interventions in the U.S. is crucial due to the bipartisan consensus on high drug costs. Recent research highlights key market dynamics such as information asymmetries, insurance-driven demand, and the role of patents in stimulating innovation. Unlike perfectly competitive markets, […]

The landscape of pharmaceutical pricing in the United States has been tumultuous, to say the least, with President Trump’s recent executive order on most-favored-nation (MFN) pricing sending ripples through the industry. While the intent behind this move aims to address the exorbitant costs often associated with healthcare and pharmaceuticals, the repercussions of slashing drug prices […]

The quest for excellence in the pharmaceutical industry demands a paradigm shift in training methodologies, transcending the confines of traditional approaches to embrace the power of digital tools and innovative technologies. The recent discussions at the PDA Regulatory Conference 2025 shed light on the imperative need to optimize training for performance, emphasizing the transition from […]

The dynamics of global health are constantly evolving, shaped by a myriad of factors ranging from regulatory decisions to pharmaceutical export strategies. In this ever-changing landscape, recent developments have captured the attention of stakeholders worldwide. From the European Union’s acknowledgment of Brazil’s bird flu-free status to Florida’s contentious stance on vaccine mandates, and India’s pivot […]

In the intricate landscape of the pharmaceutical industry, the realm of anti-counterfeit pharmaceutical packaging emerges as a critical bastion against the rising tide of counterfeit drugs, stringent regulatory oversight, and escalating consumer demand for product integrity. The imperative for robust anti-counterfeit packaging solutions transcends mere protection; it serves as a cornerstone for upholding patient health, […]

In a dynamic session at the PDA Regulatory Conference 2025 in Washington, DC, industry experts Charles Gibbons of Lachman Consultants and Michael Grischeau of AbbVie shed light on the pivotal role of AI governance, data integrity, and human supervision in revolutionizing quality assurance across pharmaceutical laboratories and supply chains. Regulatory Guidance and AI Implementation in […]

The pharmaceutical landscape in the United Kingdom is currently embroiled in a tumultuous affair with foreign investment, a relationship strained by the contentious issue of drug pricing amidst a standoff with the UK government. This discord has cast a shadow over the industry, leading to a palpable decline in investments from overseas stakeholders. As negotiations […]

The pharmaceutical industry is abuzz with anticipation as three key players, Zydus Lifesciences, Jagsonpal Pharma, and Biocon Biologics, take center stage in today’s trade, each with significant developments that are capturing the attention of investors and industry insiders alike. Zydus Lifesciences Forges a Lucrative Partnership with Synthon Zydus Lifesciences recently made waves by announcing a […]

In the realm of healthcare advancements, collaborations between pharmaceutical companies play a pivotal role in driving innovation, expanding access to medicines, and ultimately enhancing the well-being of populations. One such groundbreaking partnership that has recently come to light is the Memorandum of Understanding (MoU) signed between Nigerian pharmaceutical powerhouse, Fidson Healthcare, and Japanese firm Ohara […]

Fidson Healthcare Plc and Ohara Pharmaceutical Co., Limited have embarked on a journey to reshape Africa’s healthcare landscape through an enhanced strategic partnership. This groundbreaking move, unveiled at the 9th Tokyo International Conference on African Development (TICAD9), represents a significant leap forward in bolstering healthcare provisions across the African continent. The delegation from Fidson, spearheaded […]

In the realm of pharmaceutical exports, India is embarking on a transformative journey, seeking to expand its market presence beyond the shores of the United States. With a keen eye on mitigating risks associated with U.S. tariffs, Indian officials are setting sail towards semi-regulated markets in Africa, Latin America, and Southeast Asia. This strategic pivot, […]

Vertex Pharmaceuticals, a prominent player in the pharmaceutical industry listed on NASDAQ as VRTX, recently garnered attention following the FDA approval of JOURNAVX for acute pain management. While this approval marks a significant milestone for the company, Vertex has been steadfast in its mission to expand and diversify its extensive cystic fibrosis (CF) portfolio, solidifying […]

AstraZeneca, a leading pharmaceutical player, has hit the brakes on its planned £200 million expansion of the Cambridge research facility in eastern England. This decision resonates as a poignant setback for foreign investments in the United Kingdom, a narrative that has been gaining momentum with the recent retreats of major pharmaceutical giants from the UK […]

In a significant legal development, Texas Attorney General Ken Paxton recently announced a groundbreaking $720 million multistate settlement with eight major pharmaceutical companies. This landmark agreement includes industry giants such as Mylan (now Viatris), Hikma, Amneal, Apotex, Indivior, Sun, Alvogen, and Zydus. The settlement aims to hold these companies accountable for their role in manufacturing […]

Alembic Pharmaceuticals Limited recently achieved a significant milestone with the approval of its Abbreviated New Drug Application (ANDA) by the US Food & Drug Administration (USFDA). This approval is for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe. The company’s ANDA has been deemed therapeutically equivalent to the reference listed drug product (RLD), […]

Alembic Pharma, a leading Indian pharmaceutical company, has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API – I & API – II Facility in Panelav. This achievement follows a thorough inspection conducted from 26th May, 2025 to 31st May, 2025, during which the facilities initially received […]

The Central Drug Standard Control Organisation (CDSCO) recently made a decision regarding Zydus Lifesciences’ proposal for a phase III clinical trial of Voclosporin capsule 7.9 mg. The Subject Expert Committee (SEC) within CDSCO declined the request due to insufficient efficacy and safety data, particularly concerning the suitability of the dosage for the Indian population. This […]

The Terminal Sterilization Services Market is poised for significant expansion, with a forecasted surge from USD 15.6 billion in 2025 to a staggering USD 59.8 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 14.4%. This growth is primarily driven by the increasing demand for safe and effective infection control solutions within […]

Quotient Sciences and CPI have joined forces, orchestrating a symphony of innovation through a memorandum of understanding (MoU) to establish a joint venture (JV) aimed at expediting the advancement of RNA-based therapies. By uniting Quotient Sciences’ Translational Pharmaceutics platform with CPI’s proficiency in small-scale manufacturing of RNA and LNP encapsulation, this collaboration seeks to introduce […]

In the bustling hub of South San Francisco, a groundbreaking collaboration has emerged between Circle Pharma, Inc., and Eli Lilly and Company. Circle Pharma, known for its trailblazing work in developing next-generation targeted macrocycle therapeutics for challenging cancers, has entered into an agreement with Eli Lilly to harness the power of Lilly TuneLab. This cutting-edge […]

In a significant stride towards addressing autoimmune disorders, Mankind Pharma Ltd., a renowned pharmaceutical company, has garnered approval from the Central Drugs Standard Control Organisation (CDSCO) to commence Phase 1 clinical trials for MKP11093, a novel JAK-1 inhibitor to be administered orally. The drug candidate, MKP11093, is designed to target a spectrum of autoimmune conditions, […]

The Indian Pharmaceutical Market (IPM) continues to showcase robust growth, with an impressive 8.7% increase in August 2025, culminating in sales worth Rs 20,984 crore. These findings, as reported by the latest PharmaTrac Industry Report by Pharmarack, shed light on the dynamic landscape of the pharmaceutical industry in India. Steady Expansion Amidst Changing Dynamics In […]

Lupin, a pharmaceutical powerhouse, recently experienced a notable surge in its shares, with a 3% increase following a positive upgrade from Investec to a ‘buy’ rating. This surge comes at a time when Lupin’s stock valuations have become more appealing after a recent pullback in the market. Let’s delve into the details of this significant […]

Dr. Reddy’s Laboratories, a prominent pharmaceutical company based in Hyderabad, India, recently underwent a Pre-Approval Inspection (PAI) by the United States Food & Drug Administration (USFDA) at its biologics manufacturing facility in Bachupally, Hyderabad. The inspection took place over a period from September 4, 2025, to September 12, 2025, resulting in the issuance of a […]

In the fast-paced world of product handling and distribution, ensuring safety, quality, and compliance has become paramount. This need has propelled the growth of the time temperature indicator (TTI) labels market, a dynamic sector focusing on smart solutions for monitoring temperature conditions during storage and transportation. These innovative labels offer a visual cue indicating whether […]

The global Pharmaceutical Cleaning Validation Market, valued at USD 20.3 billion in 2025, is anticipated to surge to USD 39.3 billion by 2035, with a compound annual growth rate (CAGR) of 6.8%. This growth trajectory is primarily steered by stringent regulatory requirements, advancements in analytical tools, and the escalating production of highly potent active pharmaceutical […]

The recent reprimand by the FDA towards Amneal Pharmaceuticals serves as a stark reminder of the critical importance of upholding stringent manufacturing standards in the pharmaceutical industry. The issuance of a warning letter to Amneal, highlighting “significant violations” discovered during an inspection of their Gujarat, India facility, sheds light on the serious implications of non-compliance […]

The Food and Drug Administration (FDA) recently delivered a severe reprimand to Amneal Pharmaceuticals, highlighting what it termed as “significant violations” of manufacturing standards. The FDA specifically pointed out instances where Amneal Pharmaceuticals utilized contaminated IV bags during the production of certain injectable medications. Amneal Pharmaceuticals is a reputed company engaged in the development, manufacturing, […]

Ajanta Pharma, a prominent pharmaceutical company, has recently achieved a significant milestone by obtaining approval from the US Food and Drug Administration (USFDA) for a generic version of an acid reflux medication. This development marks a crucial step for Ajanta Pharma in expanding its presence in the highly competitive pharmaceutical market. The life sciences Global […]

Sun Pharma, a renowned pharmaceutical company, recently received the “Official Action Indicated” (OAI) classification from the U.S. Food and Drug Administration (USFDA) for its Halol facility. This classification follows a Good Manufacturing Practices (GMP) inspection conducted from 02 June to 13 June 2025. The OAI status signifies that the FDA has identified certain areas where […]

The landscape of pharmaceutical investment in the UK is facing a precarious situation, as highlighted by the recent decision of Merck & Co. Inc. to cancel its planned London research center. Oxford professor John Bell, a key figure in coordinating efforts during the COVID-19 vaccine rollout, expressed concerns over the diminishing attractiveness of the UK […]

In recent years, the United States has been grappling with a devastating opioid epidemic that has not only taken a toll on public health but has also significantly impacted the legal system. One of the key aspects of addressing the fallout from the opioid crisis has been the role of U.S. bankruptcy courts in handling […]

Madrigal Pharmaceuticals has recently garnered attention from financial experts, with 6 analysts offering a range of perspectives on the company’s performance. These analysts have shared varying views, from bullish to bearish, shedding light on the evolving sentiments surrounding Madrigal Pharmaceuticals over the past quarter. Analyst Ratings Overview The recent evaluations by analysts provide a glimpse […]

In the realm of pharmaceutical breakthroughs and scientific innovations, Lupin Limited emerges as a formidable player with its recent milestone achievement. The announcement of the United States Food and Drug Administration (U.S. FDA) approval for Lupin’s Risperidone Long-Acting Injectable marks a significant leap forward in drug delivery technology. This approval not only signifies a pivotal […]

In a groundbreaking move for the biopharma industry, Jazz Pharmaceuticals plc has achieved a monumental milestone with Modeyso (dordaviprone) being included in the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for H3 K27M-mutant Diffuse Glioma. This pivotal moment marks a significant advancement in the treatment landscape for this ultra-rare and aggressive brain tumor, bringing […]

In the realm of product liability lawsuits within the biopharma industry, every legal step taken can have far-reaching implications, shaping the landscape of accountability and responsibility. Recently, a significant development unfolded as a federal judge paved the way for a product liability suit concerning recalled Robitussin cough syrup. The case centers around the alleged link […]

FDA Unveils Novel Pathway for Rare Disease Drug Reviews The FDA has introduced the Rare Disease Evidence Principles (RDEP) program, aimed at expediting the development and review of drugs for ultra-rare diseases affecting fewer than 1,000 people in the U.S. This initiative, under Commissioner Marty Makary’s leadership, seeks to provide clear and consistent guidelines for […]

Biocon Limited, a prominent global biopharmaceutical company, recently made a significant move by inaugurating its first U.S. manufacturing facility in Cranbury, New Jersey. This expansion, facilitated through its subsidiary Biocon Generics Inc (BGI), involved a substantial investment of over USD 30 million to revamp the facility into a cutting-edge plant with an annual production capacity […]

Introduction: Aurobindo Pharma, a key player in the pharmaceutical industry, recently underwent scrutiny by the United States Food and Drug Administration (USFDA) for its Unit-XII facility located in Telangana. This inspection resulted in the issuance of eight observations, shedding light on areas that may require improvement within the company’s oral solids and injectable manufacturing unit […]

Welcome to the thrilling world of AbbVie Inc. and the dizzying heights its stock has reached! Today, we delve into the reasons behind AbbVie’s upward trajectory and what this means for investors and enthusiasts alike. In a recent SEC filing, AbbVie disclosed a significant development – a settlement of litigation with various generic drug manufacturers. […]

Merck, a pharmaceutical behemoth, recently made shockwaves in the industry by announcing the halt of its £1 billion London headquarters project. This decision comes as a severe blow to the UK’s life sciences sector, raising questions about the country’s support for critical industries. Let’s delve into the factors behind Merck’s abrupt change in direction and […]

The recent announcement of MSD’s decision to exit the UK market has sent shockwaves through the pharmaceutical industry and sparked concerns about the implications for patients, healthcare providers, and the economy. As the government scrambles to renew talks and salvage the situation, it is crucial to analyze the potential repercussions of this move on various […]

The pharmaceutical industry is a dynamic and highly regulated sector that faces unique challenges in managing supply chains and maintaining compliance with stringent regulations. From raw material sourcing to final product delivery, pharmaceutical manufacturers must navigate a complex web of suppliers, distributors, and regulatory bodies to ensure the safety, quality, and efficacy of their products. […]

Zentiva, the vibrant generics company, is on the brink of a groundbreaking transition as reports reveal its forthcoming acquisition by US investment powerhouse GTCR in a staggering €4.1 billion deal. This move marks the second private equity shift of a European pharmaceutical giant this month, injecting a fresh wave of dynamism into the industry. TheFinancial […]

In the dynamic landscape of pharmaceuticals, the UK finds itself at a crossroads, grappling with a decline in pharmaceutical investment, research and development, and clinical trials. The latest Pharmaceutical Competitiveness Framework, a collaboration between the ABPI and PwC, sheds light on the UK’s slipping position in the global pharmaceutical arena. By benchmarking the UK against […]

Despite the growing acknowledgment of the gender disparity in STEM fields, women remain notably underrepresented in leadership positions within the bioprocessing industry. This article aims to highlight the exceptional women who are shattering barriers, establishing new benchmarks, and propelling innovation within this realm. These visionary women are at the forefront of shaping the future of […]

Eli Lilly, a stalwart in the pharmaceutical industry, has unveiled a groundbreaking initiative that could revolutionize the landscape of drug discovery and development. The introduction of AI-powered models through Lilly TuneLab represents a significant strategic move, aimed at fostering collaborations with biotech partners by offering access to cutting-edge technology developed through substantial investment. This innovative […]

India’s pharmaceutical sector is experiencing unprecedented growth, fueled by a surge in exports and increasing foreign investments. The regulatory landscape has also evolved significantly, with notable enhancements such as the revamped CDSCO website and the widespread adoption of the ONDLS platform by state authorities. These changes have not only streamlined processes but have also increased […]

Indian pharmaceutical companies are undergoing a remarkable transformation, steering away from the conventional path of replicating blockbuster drugs. Instead, they are venturing into the realm of innovation by harnessing the power of the US FDA’s 505(b)(2) regulatory pathway. Dr. Hemagir Gosavi, the dynamic manager of the Formulation and Technology Centre at Merck Life Sciences, highlights […]

The Trump administration has identified a critical issue concerning the security of the United States’ drug supply chain. The current dependence on foreign countries, particularly China, for the manufacturing of essential pharmaceuticals poses a significant national security risk. China’s involvement in producing a large percentage of generic antibiotics and active pharmaceutical ingredients consumed by Americans […]

IPG Health, a powerhouse in healthcare marketing solutions, is making waves with its latest move to expand its acclaimed Influencer ID services into Europe. This strategic decision aims to replicate the success witnessed in the US and inject fresh energy into key European markets, solidifying the network’s position as a leader in social media strategy […]

In 2025, at the prestigious 34th Economic Forum in Karpacz, a panel discussion titled ‘Drug safety and competitiveness of the pharmaceutical industry in the new geopolitical reality’ brought together key figures in the European pharmaceutical landscape. The focus was on finding the delicate balance between fostering innovation, ensuring drug safety, and maintaining competitiveness in the […]

In the fast-paced landscape of the pharmaceutical industry, the importance of optimizing training for performance cannot be overstated. The recent discussions at the PDA Regulatory Conference 2025 shed light on the necessity of moving beyond traditional compliance-focused training methods towards embracing digital tools to enhance learning outcomes. As industry experts Marc Glogovsky and Richard Jaenisch […]

The recent session at the Parenteral Drug Association (PDA) Regulatory Conference 2025 in Washington, DC delved into the critical role of artificial intelligence (AI), digital governance, and data integrity in shaping quality assurance within pharmaceutical manufacturing. Charles Gibbons from Lachman Consultants and Michael Grischeau from AbbVie highlighted the significance of AI governance, data integrity, and […]

In the high-stakes arena of pharmaceutical pricing, US President Donald Trump has thrown down the gauntlet, demanding that major drug companies commit within weeks to his “most-favoured nation” policy. This policy, aimed at ensuring that the US pays less for drugs than other comparable countries, is a bold move in Trump’s ongoing crusade to overhaul […]

Denis Johnson, a seasoned industry executive with 25 years of experience, has assumed the role of CEO at Grand River Aseptic Manufacturing Inc. (GRAM), a prominent contract development and manufacturing organization based in Grand Rapids. Amidst a period of rapid growth within the pharmaceutical industry, Johnson’s leadership comes at a pivotal time for the company […]

Welcome to Pharma Pulse, a platform that delves into the latest trends and happenings in the pharmaceutical world. In this episode, we unearth intriguing reports on a White House executive order contemplating restrictions on treatments originating from China, the impressive immune response data from Pfizer and BioNTech’s COVID-19 vaccine, and the strategic move by Samsung […]

In a bold move that has stirred up controversy within the pharmaceutical and investment worlds, White House officials are reportedly crafting an executive order aimed at imposing stringent restrictions on experimental treatments originating from China. This potential order has ignited a flurry of lobbying activities from various stakeholders, including influential investors and top pharmaceutical companies, […]

Excipients, the unsung heroes of pharmaceutical products, play a crucial role in drug formulation and delivery. While active pharmaceutical ingredients (APIs) take the spotlight, excipients work behind the scenes to enhance product stability, solubility, and overall effectiveness. In the realm of biopharmaceuticals, such as vaccines, gene therapy, and cell therapy products, excipients are even more […]

The K-Bio Pharmaceutical Industry is gearing up to transform into a global powerhouse, aiming to secure a spot among the top five players on the world stage. This ambitious goal was underscored by a recent Inter-ministerial roundtable that brought together key stakeholders from government bodies, leading pharmaceutical companies, research institutes, and academic organizations. The event, […]

Depression, a pervasive mental health condition affecting over 280 million individuals worldwide, transcends boundaries of age, gender, and geography. Despite its prevalence, misconceptions persist, such as the oversimplified advice to “just snap out of it.” Modern neuroscience and extensive clinical research reveal the intricate interplay of brain chemistry, genetics, environment, and psychology in shaping depression. […]

In the realm of neuroscience, a groundbreaking advancement has emerged in the form of a wireless, implantable neural interface designed to deliver drugs with unparalleled precision to deep regions of the brain. Developed by a team led by Professor Kyung-In Jang at DGIST, this innovative device features a soft, flexible micro-pump and channel structure that […]

Benzinga Rankings offer invaluable metrics on stocks, including ACADIA Pharmaceuticals (ACAD), which has garnered attention from 12 financial analysts in the past three months. These analysts present a spectrum of perspectives ranging from bullish to bearish, shaping the evolving sentiments surrounding the company. The analysts’ recent ratings provide a comprehensive view of ACADIA Pharmaceuticals, highlighting […]

Three brilliant minds have reshaped the landscape of cystic fibrosis treatment, earning them the esteemed Lasker Award, a prestigious accolade in the medical realm. Paul Negulescu from Boston-based Vertex Pharmaceuticals, Jesús (Tito) González, a former researcher at Vertex, and Michael Welsh from the University of Iowa, have been honored for their groundbreaking contributions that have […]

India’s leading pharmaceutical companies, Sun Pharmaceutical Industries and Lupin Ltd, are making significant strides in the development of cost-effective anti-obesity drugs amidst a rising health concern in the country. With approval from the Drugs Controller General of India (DCGI), both Sun Pharma and Lupin are progressing their obesity drug programs to offer more affordable alternatives […]

Sanofi, a prominent pharmaceutical company, has recently received an upgrade from Morgan Stanley, shifting its rating to “overweight” from “equal-weight.” This upgrade was fueled by promising developments surrounding amlitelimab, Sanofi’s OX40L antibody designed for treating atopic dermatitis. Although amlitelimab did not surpass the efficacy of Dupixent, a well-known therapy, clinical trials have shown consistent benefits […]

Benzinga Rankings offers a unique window into the dynamics of any stock, at any moment, empowering investors with critical insights. Rhythm Pharmaceuticals (RYTM) has seen a significant uptick in short interest, with the percentage of shares sold short as a percent of float climbing by 6.31% in the latest report. This surge translates to around […]

The 2025 PDA Regulatory Conference was a hub of vibrant discussions and cutting-edge insights into the ever-evolving landscape of regulatory compliance in the biotech industry. Industry experts and thought leaders gathered to delve into a multitude of topics, ranging from quality culture to artificial intelligence, all aimed at enhancing regulatory practices and ensuring the highest […]

In an effort to streamline the regulatory procedures for biopharmaceutical companies involved in the development of vaccines, recombinant DNA products, and other biological substances, the Central Drugs Standard Control Organization (CDSCO) has introduced a new directive. This circular states that approvals granted by Institutional Biosafety Committees (IBSC) will now be recognized when seeking permission to […]

In the fast-paced world of pharmaceutical manufacturing, ensuring quality and safety standards are met is paramount. Merck’s Sanat Chattopadhyay, the executive vice-president and president of the Merck Manufacturing Division, recently delivered a compelling address at the PDA Regulatory Conference 2025 in Washington, DC. His message centered around the critical importance of strong leadership, data-driven oversight, […]

Odyssey Therapeutics, a company dedicated to combating autoimmune and inflammatory diseases, faced a setback earlier this year when their initial public offering plans fell through amidst a challenging market climate for biopharma companies. Turning adversity into opportunity, Odyssey swiftly rebounded by securing an impressive $213 million in a series D fundraising round. This substantial injection […]

Intercept Pharmaceuticals recently made the decision to withdraw Ocaliva from the U.S. market following concerns raised by the FDA regarding the drug’s safety and effectiveness in treating primary biliary cholangitis (PBC). This move marks a significant setback for Ocaliva, especially after it was denied full approval by the FDA last year due to identified cases […]

In the fast-paced world of healthcare, recent developments have brought key players into the spotlight. Intercept Pharmaceuticals made waves with its decision to withdraw Ocaliva, a liver disease drug, from the U.S. market following safety concerns raised by the FDA. Meanwhile, regulatory focus is shifting towards AI digital health devices, with the FDA gearing up […]

Blow Fill Seal (BFS) technology is at the forefront of transforming pharmaceutical packaging, with the market projected to witness substantial growth from USD 3.2 billion in 2025 to USD 5.4 billion by 2035, marking a CAGR of 5.4%. This innovative technology integrates container formation, filling, and sealing into a single automated process, ensuring high-quality, sterile […]

When taking prescription medication, understanding how the body processes drugs and the impact of dosage and timing is crucial. Pharmacokinetics (PK) focuses on how drugs are absorbed, distributed, metabolized, and eliminated in the body over time, while pharmacodynamics (PD) examines how drug concentrations affect physiological systems and produce responses. With half of all adults and […]

The analytical instrument industry experienced robust growth in the second quarter of 2025, driven primarily by significant demand from the pharmaceutical and chemical sectors. Major suppliers in this field not only met but often surpassed expectations, with optimistic projections for sustained growth throughout the remainder of the year. This upsurge in revenue was underpinned by […]

Pharmexcil, the Pharmaceutical Export Promotion Council of India, is advocating for the alignment of Goods and Services Tax (GST) rates within the pharmaceutical industry to streamline compliance processes and address the existing inverted duty structure. At present, there is a notable tax gap between active pharmaceutical ingredients (APIs) and formulations, leading to inefficiencies within the […]

DHL Global Forwarding has advanced its cold chain logistics offerings in Asia Pacific through the inauguration of a cutting-edge pharmaceutical facility at Kuala Lumpur International Airport (KLIA). This strategic move not only solidifies DHL’s position as a prominent player in healthcare logistics but also caters to the escalating need for temperature-sensitive pharmaceutical transportation in the […]

Today, August 27th, marks a pivotal moment for the pharmaceutical industry as wholesale distributors are now required to fully comply with the Drug Supply Chain Security Act (DSCSA). This signifies the closure of the FDA’s exemption period and a significant step forward in enhancing patient safety and fortifying the integrity of the pharmaceutical supply chain. […]

Six analysts recently shared their perspectives on NewAmsterdam Pharma Co (NAMS), offering a range of opinions from bullish to bearish. Their 12-month price targets for NAMS average $39.50, with a high estimate of $45.00 and a low of $27.00, indicating a 1.28% increase from the previous average target of $39.00. These ratings reflect evolving sentiments […]

New research has unveiled the potential of breathwork combined with music to induce profound altered states of consciousness akin to those triggered by psychedelic substances. This study, led by Amy Amla Kartar and her team at the Colasanti Lab in Brighton and Sussex Medical School, U.K., utilized self-reports and brain imaging to delve into the […]

UMass Lowell has inaugurated the Lyophilization Research Bay (LyoBay), a cutting-edge facility that stands as the premier pilot-scale establishment on the East Coast situated within a clean-room environment. This facility is open to external users, enabling students, researchers, and industry partners to conduct experiments on freeze-drying processes critical for enhancing the production of pharmaceuticals and […]

Dr. Reddy’s Laboratories has achieved a significant milestone by introducing Linaclotide, a novel medication designed to address chronic constipation in adults. This pharmaceutical breakthrough, marketed under the brand name Colozo, has garnered regulatory approval in India, positioning Dr. Reddy’s as the pioneering company to offer this treatment option in the country. Available in doses of […]

DHL Global Forwarding has recently expanded its cold chain capabilities at Kuala Lumpur International Airport, introducing a new 3,500 square meter storage facility that is dual-certified to accommodate products requiring specific temperature ranges. The facility, equipped with DHL Air GxP and IATA CEIV Pharma certifications, aims to bolster support for the Pharmaceutical and Life Science […]

The chromatography software market is on a trajectory to double in value, reaching an impressive US$ 14.3 billion by the year 2030, with a robust compound annual growth rate (CAGR) of 8.1% from 2022 to 2030. This growth is underpinned by the critical role that chromatography software plays in chromatography-based analysis, facilitating data collection, processing, […]

In a groundbreaking move, EVERSANA and Waltz Health have merged to create a unified platform aimed at revolutionizing the pharmaceutical commercialization landscape. By combining EVERSANA’s extensive commercialization services with Waltz Health’s AI-powered payer tools, the partnership seeks to address patient affordability, streamline drug access, and drive down costs for high-expense therapies like GLP-1s. This collaboration […]

A recent study has confirmed that the biosimilar romiplostim, known as GP40141, provides efficacy and safety comparable to the reference product in treating immune thrombocytopenia (ITP), offering a promising alternative for patients. In a multicenter, single-blind, randomized controlled trial, the biosimilar GP40141 was evaluated for its performance in adult patients with persistent or chronic ITP. […]

Agilent Technologies, a renowned player in the biopharma and quality control sectors, recently disclosed its impressive performance for Q3 FY2025. The company’s revenue soared to $1.74 billion, marking a 6.1% year-over-year increase on a core basis, accompanied by a non-GAAP EPS of $1.37, surpassing initial projections. Despite facing elevated tariff expenses, Agilent raised its full-year […]

Non-pharmacological interventions, psychosocial support, and communication strategies play a crucial role in improving pain management, emotional well-being, and treatment adherence in cancer care. These approaches were highlighted in a study abstract presented at the 2025 ASCO Annual Meeting, showcasing significant benefits for cancer patients. Dr. Fnu Anamika, the lead author of the study, emphasized the […]

Humana, a prominent healthcare provider, is expanding its focus on value-based care to enhance support for Medicare Advantage members dealing with musculoskeletal (MSK) conditions. These conditions, ranging from arthritis to back and joint pain, affect over half of U.S. adults and are a leading cause of disability nationwide. The direct healthcare costs associated with MSK […]

A major milestone has been achieved in the realm of cancer treatment as CuraTeQ Biologics, a subsidiary of Aurobindo Pharma Ltd., has successfully obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dazublys, its biosimilar version of trastuzumab. This approval in the UK follows a series of successful authorizations in […]

The Protein A Resin Market is on a trajectory to reach a valuation of US$2.0 billion by 2030, with a robust CAGR of 6.5% from 2025 to 2030. This growth is primarily fueled by the escalating demand for monoclonal antibodies (mAbs) and the emergence of novel biologics like bispecifics and antibody-drug conjugates. As the global […]

The global Cloud-Based Drug Discovery Platform Market is on track for explosive growth, with projections soaring to USD 11.3 billion by 2035 from USD 3.5 billion in 2025. This anticipated leap reflects a robust compound annual growth rate (CAGR) of 12.6% over the forecast period, indicating a substantial shift in how pharmaceutical and biotech sectors […]

Pharmaceutical stocks, including Ajanta Pharma, Gland Pharma, Lupin, Aurobindo Pharma, Sun Pharmaceutical Industries, Zydus Lifesciences, Divi’s Laboratories, and Torrent Pharmaceuticals, faced a significant downturn, with the Nifty Pharma index dropping over 1% in a single session. The slump coincided with a general market decline following the activation of an additional 25% tariff on Indian goods […]

In the realm of healthcare, the shift towards value-driven pharmacy services has become a focal point for organizations striving to enhance patient outcomes while optimizing costs. Pharmacy executives from various hospitals and health systems in the United States have been sharing their recent successes in this area, shedding light on innovative strategies and initiatives that […]

DHL Global Forwarding is elevating its capabilities in Asia Pacific’s life science and healthcare sector by introducing a dual-certified cold chain facility in Malaysia. This facility, situated within the Kuala Lumpur International Airport Free Commercial Zone, spans 38,000 square feet and is the first of its kind to be certified for both 15-25°C and 2-8°C […]

Resistance has long been a driving force for progress in society, as emphasized by Frederick Douglass’s famous words. In the context of America’s healthcare disparities, these words hold true today more than ever. Despite significant advancements in health care, housing, and job opportunities for minority and non-minority low-income groups in Virginia under Gov. Glenn Youngkin, […]

Tata Consultancy Services (TCS) has joined forces with Unilab, Inc., a prominent pharmaceutical and healthcare company based in the Philippines, to initiate a transformative cloud-led enterprise modernization project. This collaboration will see TCS assisting Unilab in transitioning from its traditional enterprise resource planning (ERP) system to a modern, cloud-based digital core. By leveraging SAP S/4HANA […]

India’s Contract Research, Development, and Manufacturing Organization (CRDMO) sector is experiencing a significant surge, emerging as a key player in the global pharmaceutical market. Recently, a report by Jefferies India revealed that the Indian CRDMO sector has already achieved revenues of approximately $3 billion, with a notable compound annual growth rate (CAGR) of 14% over […]

In a bid to support the African Union’s ambition of bolstering local production of medicines and vaccines across the continent, Egypt and India have engaged in discussions exploring collaborative ventures. Egypt’s Deputy Prime Minister and Minister of Health, Khaled Abdel Ghaffar, recently convened with Indian Ambassador to Cairo, Suresh K. Reddy, and his team to […]

The pharmaceutical market in India is set to experience significant growth, with projections indicating a doubling of its current value from USD 60 billion to an estimated USD 120 billion by the year 2030. This forecast comes from a collaborative report by the Organisation of Pharmaceutical Producers of India (OPPI) in partnership with the Boston […]

India’s pharmaceutical sector has managed to navigate through the recent US tariff hikes largely unscathed due to its pivotal position as a major supplier of generic drugs, ensuring a continued flow of affordable medicines to the American healthcare system. Despite the imposition of additional tariffs on Indian imports by President Donald Trump, pharmaceutical exports from […]

The biosimilar market in India is anticipated to surpass $40 billion by the year 2030, showcasing a significant upward trend in the pharmaceutical industry. Noteworthy recent developments include Intas Pharma’s successful completion of the USD 558 million acquisition of UDENYCA biosimilar and Sun Pharma’s agreement with Taro for a $200 million US antitrust settlement. These […]

Canarys has recently launched Auryis, an innovative AI-powered compliance platform tailored for the Pharma and Life Sciences sectors, marking a strategic shift towards a product-centric approach. Auryis stands out by providing real-time compliance insights, aligning digital content with regulatory requirements like GxP, FDA, and EMA, as well as internal standards. This platform aims to streamline […]

The pharmaceutical supply chain is facing potential disruptions due to proposed tariffs on pharmaceutical imports, prompting concerns about excess inventory, increased waste, and financial strains on companies. Dave Malenfant, a healthcare supply chain expert, highlights the complexities of these tariffs in a recent interview, emphasizing the importance of strategic renegotiation to mitigate adverse effects. The […]

Decentralized Clinical Trials (DCT) have gained attention for their potential to enhance patient diversity and retention. Despite the strong data supporting their benefits, widespread adoption of DCT models has been slow within the biopharma industry. Sunny Kumar, MD, a partner at Informed Ventures, highlighted key obstacles hindering the large-scale implementation of decentralized trials in a […]

Scott Gottlieb, the former FDA commissioner under the Trump administration, expressed concerns in a recent editorial published in the Journal of the American Medical Association (JAMA) regarding the potential for the US to lose its leading position in the global biopharmaceutical landscape. Gottlieb highlighted China’s rapid advancements in bringing new drugs to market, suggesting that […]

China’s pharmaceutical market has been experiencing rapid growth, with projections indicating that it will reach $161.8 billion by 2023, representing a significant 30% share of the global market. Industry expert Fu Xudong, the senior vice president of Bristol-Myers Squibb, highlighted during the World Innovators Meet 2019 that China has emerged as the world’s second-largest pharmaceutical […]

In the bustling world of pharmaceuticals, significant moves and advancements are constantly shaping the landscape. AbbVie recently made waves by securing a deal worth up to $1.2 billion to acquire Gilgamesh Pharmaceuticals’ experimental psychedelic drug for treating major depression. This strategic decision not only underscores AbbVie’s increasing focus on neuroscience but also highlights the growing […]

SRx Health Solutions Inc., a Canadian specialty pharmacy chain and clinic network catering to patients with complex medical conditions, has filed for creditor protection under the Companies’ Creditors Arrangement Act. The company, founded in 2013 by pharmacist Adesh Vora, operated 17 specialty pharmacies and 19 clinics across Canada, employing over 200 staff. The trouble began […]

MannKind Corporation recently announced its acquisition of scPharmaceuticals Inc. for a deal valued at approximately $360 million, signaling a strategic move into the field of cardiorenal medicine. This acquisition not only expands MannKind’s portfolio but also establishes its presence in the cardiometabolic sector alongside its existing orphan lung division. The deal was made possible following […]

US President Donald Trump’s decision to impose punitive tariffs on Indian goods has significant implications for the country’s exports to the US. Initially set at 25%, the tariffs have now been raised to 50%, particularly affecting Indian imports of Russian oil. Despite this, around 30% of India’s exports to the US, valued at $27.6 billion, […]

In the current landscape of political volatility and heightened public skepticism towards the pharmaceutical industry, the role of a pharmaceutical CEO has become increasingly challenging. Executives are grappling with rapidly shifting policies, escalating drug pricing scrutiny, market instability, and investor anxiety. The demands placed on pharma CEOs in these tumultuous times are daunting, with the […]

In 2024, the biopharmaceutical industry experienced a notable growth recovery, with 19 of the top 20 publicly traded global biopharma companies reporting revenue growth. The total revenue for these companies increased by over 7.9% to $880.4 billion from 2023 to 2024, as reported by GlobalData. Among the top performers were Eli Lilly, with a 32% […]

Akums Pharmaceuticals, a prominent player in the pharmaceutical manufacturing sector, has recently forged a strategic partnership with the Government of the Republic of Zambia (GRZ) to inaugurate a cutting-edge manufacturing facility in Zambia. This collaboration aims to provide the local population with access to high-quality and cost-effective generic medications, catering to the healthcare needs of […]

AbbVie Inc. has recently announced a significant agreement to acquire the lead investigational candidate for moderate-to-severe major depressive disorder (MDD) from Gilgamesh Pharmaceuticals Inc. This deal, valued at up to $1.2 billion, includes upfront payment and development milestones for the bretisilocin program. As part of this transaction, Gilgamesh will establish a new entity, Gilgamesh Pharma […]

The recent implementation of 50% US tariffs on Indian goods has stirred the financial markets, leading to a lower opening for key indices like the Sensex and Nifty. The Sensex commenced at 80,754, slightly down from its previous close of 80,786, while the Nifty opened at 24,711 compared to the earlier close of 24,712. Sectors […]

Innocan Pharma Corporation is set to present groundbreaking findings at the upcoming PAINWeek 2025 Conference in Las Vegas, Nevada. The company will showcase a scientific poster detailing key data on LPT-CBD pharmacokinetics and efficacy, along with a recently published narrative review highlighting the potential of long-acting synthetic Cannabidiol (CBD) for chronic pain management. This presentation […]

Schreiner MediPharm, a prominent healthcare label solutions provider from Germany, has collaborated with Bluesight to introduce an innovative RFID-enabled labeling system. This technology aims to revolutionize digital inventory management within hospital pharmacies, offering real-time tracking of medications and a substantial reduction in medication errors. By leveraging the robust RFID-Labels developed by Schreiner MediPharm and the […]

The Food and Drug Administration (FDA) has recently announced a significant change in its approach to monitoring drug safety by transitioning from quarterly to daily updates of adverse event reports linked to drugs and biological products. This decision, led by FDA Commissioner Marty Makary, aims to improve post-market surveillance and provide timely access to crucial […]

Pharmacovigilance, the ongoing monitoring of medical products post-approval to detect adverse reactions, plays a crucial role in safeguarding public health. Despite its importance, there is currently no universally accepted gold standard method for pharmacovigilance. Marianthi Markatou, a biostatistician at the University at Buffalo (UB), is leading a pioneering research effort to address this gap, supported […]

When we take a prescription pill, we rely on it to tackle the health issue it’s intended for. But what really goes on inside our bodies? How do drugs get processed, and what happens if the dosage or timing is incorrect? This is where pharmacokinetics (PK) and pharmacodynamics (PD) come into play, shedding light on […]

In the realm of bio/pharma, the impact of tariffs on rising costs and strained supply chains is a pressing concern. Companies are actively seeking ways to enhance compliance, diversify their sourcing, and secure stable trade conditions and R&D support. Recent survey results shed light on the challenges faced by the industry and the strategies being […]